| Oncosil Medical Limited (OSL) ORDINARY FULLY PAID |
Health Care |
$18 |
Director Appointment/Resignation PH
|
15 Jul 2024 9:09AM |
$0.007 |
$0.004 |
fallen by
42.86%
|
|
| Environmental Clean Technologies Limited (ECT) ORDINARY FULLY PAID |
Industrials |
$7 |
ECT and ESG Agriculture sign Joint Venture HOA
|
15 Jul 2024 9:09AM |
$0.003 |
$0.002 |
fallen by
33.33%
|
|
ECT - Price-sensitive ASX Announcement
Full Release
Key Points
- ECT and ESG Agriculture have signed a binding Heads of Agreement (HoA).
- The HoA replaces a prior Memorandum of Understanding (MoU) from 4 April 2024.
- The HoA outlines the development and offtake of soil health products using ECT's COLDry technology.
- Initial product output will be 30,000 tonnes per annum.
- The JV aims to validate full-scale commercial production and sales of lignite-based nitrogen fertiliser.
- ECT and ESG Agriculture will share equal ownership of the joint venture.
- The collaboration supports innovative product development, cost-effective fertilisation, and soil carbon enhancement.
- Field trials and extensive testing have shown positive results with minimal nitrogen loss.
- The JV will expand its product suite and identify additional project sites.
- Completion of the Joint Venture Agreement is targeted for 30 September 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NewPeak Metals Limited (NPM) ORDINARY FULLY PAID |
Materials |
$5 |
NewPeak closes Canadian Uranium Acquisition
|
15 Jul 2024 9:08AM |
$0.016 |
$0.015 |
fallen by
3.23%
|
|
| Resolution Minerals Ltd (RML) ORDINARY FULLY PAID |
Materials |
$6 |
Carrara Range Project Presentation
|
15 Jul 2024 9:07AM |
$0.003 |
$0.012 |
risen by
300%
|
|
| SenSen Networks Limited (SNS) ORDINARY FULLY PAID |
Information Technology |
$25 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
15 Jul 2024 9:06AM |
$0.020 |
$0.032 |
risen by
60%
|
|
SNS - Price-sensitive ASX Announcement
Full Release
Key Points
- Record quarterly customer cash receipts of over $4.0M, a 23% increase over the previous corresponding period.
- Positive operating cash flow of $0.4M for the quarter.
- Yearly customer cash receipts of over $12.4M, an 11% increase over the previous corresponding period.
- Annual operating expenses reduced from $13.4M to $10.6M.
- Debt reduced by $0.6M since June 2023.
- Dismissal of court proceedings and exit from the gaming market.
- Appointment of Mark Brayan as non-executive chairman.
- Additional system orders from NHVR, City of Vancouver, and various fuel retail brands.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dorsavi Ltd (DVL) ORDINARY FULLY PAID |
Health Care |
$7 |
dorsaVi completes clinical study with Norton Healthcare
|
15 Jul 2024 9:06AM |
$0.012 |
$0.010 |
fallen by
16.67%
|
|
DVL - Price-sensitive ASX Announcement
Full Release
Key Points
- dorsaVi has completed a clinical study with Norton Healthcare.
- The study generated approximately AUD 100,000 in research support over 24 months.
- dorsaVi used wearable sensor technology and AI/ML algorithms to investigate spinal motion and movement patterns.
- The study was conducted pre and post-surgery among patients.
- Steven Glassman, M.D., a leading orthopaedic spine surgeon, led the study.
- The research aims to support dorsaVi’s product line and enhance its top-tier client base.
- Study findings are expected to be published in peer-reviewed journals and medical conferences.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Liontown Resources Limited (LTR) ORDINARY FULLY PAID |
Materials |
$1,978 |
New short-term Offtake Agreement for initial ramp-up volumes
|
15 Jul 2024 9:05AM |
$1.000 |
$0.815 |
fallen by
18.50%
|
|
LTR - Price-sensitive ASX Announcement
Full Release
Key Points
- Liontown Resources Limited (ASX: LTR) executed a short-term Offtake Agreement with Beijing Sinomine International Trade Co., Ltd (BSIT).
- The agreement is for the supply of up to 100,000 dry metric tonnes (DMT) of spodumene concentrate over a 10-month period.
- The supply term commences by 30 September 2024.
- Pricing is determined using a formula-based mechanism referencing market prices for battery-grade lithium carbonate.
- Payment will be through an irrevocable letter of credit.
- This agreement is in addition to existing long-term offtake contracts with Tesla, LG Energy Solution, and Ford.
- Liontown's Managing Director and CEO, Tony Ottaviano, stated that securing this near-term offtake de-risks sales during the ramp-up period.
- The announcement was approved for release by the Managing Director, Tony Ottaviano.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| The Star Entertainment Group Limited (SGR) ORDINARY FULLY PAID |
Consumer Discretionary |
$316 |
System Performance Issues
|
15 Jul 2024 9:05AM |
$0.510 |
$0.110 |
fallen by
78.43%
|
|
SGR - Price-sensitive ASX Announcement
Full Release
Key Points
- System upgrades for cashless gaming introduction identified performance issues.
- Shutdown of all Electronic Gaming Machines and Electronic Table Games from 10:00pm on 13 July 2024.
- Decision made to ensure compliance with relevant regulations and maintain safer gambling procedures.
- Collaboration with external provider Konami to resolve issues.
- Treasury Brisbane, The Star Gold Coast, and The Star Sydney remain open with other gaming activities and services available.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Excite Technology Services Limited (EXT) ORDINARY FULLY PAID |
Information Technology |
$25 |
Appendix 3Y - SB
|
15 Jul 2024 9:05AM |
$0.009 |
$0.012 |
risen by
33.33%
|
|
| Excite Technology Services Limited (EXT) ORDINARY FULLY PAID |
Information Technology |
$25 |
Cleansing Notice
|
15 Jul 2024 9:04AM |
$0.009 |
$0.012 |
risen by
33.33%
|
|
| RareX Limited (REE) ORDINARY FULLY PAID |
Materials |
$19 |
RareX Board Restructure
|
15 Jul 2024 9:04AM |
$0.014 |
$0.024 |
risen by
71.43%
|
|
REE - Price-sensitive ASX Announcement
Full Release
Key Points
- James Durrant promoted from CEO to Managing Director.
- Resignations of Non-Executive Directors John Young and Cameron Henry.
- Jeremy Robinson remains as Non-Executive Chairman.
- Shaun Hardcastle and Danny Goeman remain as Non-Executive Directors.
- Changes align with RareX’s focus on Khaleesi Niobium-Rare Earths Project.
- Focus on reducing corporate overheads.
- RareX acquired Khaleesi Niobium-Rare Earths Project in East Yilgarn, WA.
- Cummins Range Project development continues.
- Shareholder approval sought for options issuance to non-executive directors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PM Capital Global Opportunities Fund Limited (PGF) ORDINARY FULLY PAID |
Financials |
$1,194 |
Net Tangible Asset Backing - 12 July 2024
|
15 Jul 2024 9:03AM |
$2.250 |
$2.490 |
risen by
10.67%
|
|
| Optiscan Imaging Limited (OIL) ORDINARY FULLY PAID |
Health Care |
$104 |
Optiscan Receives Ethical Clearance for Breast Cancer Study
|
15 Jul 2024 9:03AM |
$0.195 |
$0.125 |
fallen by
35.90%
|
|
OIL - Price-sensitive ASX Announcement
Full Release
Key Points
- Optiscan has received ethical clearance to undertake in vivo in-human imaging for breast cancer.
- The study will assess Optiscan’s InVue™ precision surgery imaging platform in breast cancer.
- Data demonstrates high concordance between Optiscan’s imaging platform and the gold standard histopathology.
- Image analysis reveals similar morphological, architectural and cellular features observed by pathologists.
- The study will be conducted at Royal Melbourne Hospital, Frances Perry House, and Epworth Hospital, overseen by Professor Bruce Mann and other leading medical professionals.
- The study will recruit 50 patients undergoing lumpectomy procedures for breast cancer.
- The clinical workflow will not interfere with standard patient care.
- Optiscan plans to progress to further recruitment with an interventional protocol once the non-interventional study phase is completed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$273 |
Weekly NTA Update
|
15 Jul 2024 9:02AM |
$2.170 |
$1.820 |
fallen by
16.13%
|
|
| Nine Entertainment Co. Holdings Limited (NEC) ORDINARY FULLY PAID |
Communication Services |
$2,426 |
Notification of Results
|
15 Jul 2024 9:01AM |
$1.385 |
$1.530 |
risen by
10.47%
|
|
| Firebird Metals Limited (FRB) ORDINARY FULLY PAID |
Materials |
$11 |
Firebird Metals Letter to Shareholders
|
15 Jul 2024 9:01AM |
$0.140 |
$0.075 |
fallen by
46.43%
|
|
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
$408 |
Weekly NTA Update
|
15 Jul 2024 9:00AM |
$1.920 |
$1.635 |
fallen by
14.84%
|
|
| AKORA Resources Limited (AKO) ORDINARY FULLY PAID |
Materials |
$16 |
Change in substantial holding
|
15 Jul 2024 8:59AM |
$0.140 |
$0.120 |
fallen by
14.29%
|
|
| Acrux Limited (ACR) ORDINARY FULLY PAID |
Health Care |
$10 |
Acrux presentation to Bioshares, 18th Biotech Summit
|
15 Jul 2024 8:59AM |
$0.065 |
$0.024 |
fallen by
63.08%
|
|
ACR - Price-sensitive ASX Announcement
Full Release
Key Points
- Acrux is a specialty pharma company developing topically applied products.
- Presentation at the 18th Bioshares Biotech Summit on July 13, 2024.
- Acrux has over 25 years of experience and multiple product approvals.
- The company focuses on the U.S. market with TGA approved GMP facilities.
- Acrux’s core business model includes identification, development, regulatory submission, and commercial launch of drugs.
- Recently launched Dapsone 5% Gel and Prilocaine/Lidocaine Cream in the U.S.
- Seven new topical prescription products are under FDA review.
- Acrux advocates for commercial partnering and product development opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Freightways Group Limited (FRW) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Industrials |
$1,715 |
Annual Shareholders Meeting
|
15 Jul 2024 8:59AM |
$7.220 |
$9.590 |
risen by
32.83%
|
|
| Terrain Minerals Limited (TMX) ORDINARY FULLY PAID |
Materials |
$7 |
Trading Halt
|
15 Jul 2024 8:59AM |
$0.004 |
$0.003 |
fallen by
14.29%
|
|
TMX - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by Terrain Minerals Limited (TMX).
- Effective from 15 July 2024.
- Pending announcement on proposed capital raising.
- Trading halt to remain until 17 July 2024 or announcement release.
- No other information deemed necessary for market.
- ASX Compliance issued the halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Incitec Pivot Limited (IPL) ORDINARY FULLY PAID |
Materials |
$4,827 |
Update - Notification of buy-back - IPL
|
15 Jul 2024 8:59AM |
$2.880 |
$2.590 |
fallen by
10.07%
|
|
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$155 |
Barton Allocated $1,488,500 in JMEI Tax Credits
|
15 Jul 2024 8:58AM |
$0.260 |
$0.710 |
risen by
173.08%
|
|
BGD - Price-sensitive ASX Announcement
Full Release
Key Points
- Barton Gold Holdings Limited has been allocated $1,488,500 in JMEI tax credits.
- The JMEI tax credits are available for distribution to new eligible investors before 30 June 2025.
- The tax credits apply to new shares issued during the 2024/2025 financial year.
- Eligible investors can receive refundable tax offsets or franking credits.
- The amount of tax credits issued to investors will depend on multiple factors such as the number of new shares issued and the allowable exploration expenditures.
- Barton Gold Holdings has a significant track record of generating non-dilutive sources of funding.
- The company is well-capitalized with over $10 million cash and has no immediate plans to raise new capital.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Solstice Minerals Limited (SLS) ORDINARY FULLY PAID |
Materials |
$20 |
New Gold Anomalism at Box Soak Spurs Follow-up Drilling
|
15 Jul 2024 8:57AM |
$0.200 |
$0.190 |
fallen by
5%
|
|
SLS - Price-sensitive ASX Announcement
Full Release
Key Points
- Reconnaissance aircore drilling at Box Soak identified a new gold zone with anomalous results over 800m of strike.
- Initial results included 5m @ 0.42g/t Au and 10m @ 0.20g/t Au.
- Gold anomalism is associated with oxidized, silicified, and sulfide-altered felsic volcaniclastic rocks.
- Further aircore drilling is planned to infill and evaluate the gold anomalism at Box Soak and Bunjarra Prospects.
- Follow-up RC drill-testing is scheduled for Q4 2024 for advanced gold prospects like Statesman Well and Bluetooth.
- The sale of the Company’s Hobbes tenement for $12.5 million to Northern Star Limited highlights commercial potential.
- Solstice Minerals holds approximately $17.5 million in cash, equating to 17.5c per share, providing flexibility to expand its asset base.
- The Box Soak Prospect lies in a promising regional structural setting north of Northern Star Resources’ Porphyry mining center and southwest of AngloGold Ashanti’s Sunrise Dam gold deposit.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Far East Gold Ltd (FEG) ORDINARY FULLY PAID |
Materials |
$51 |
New Chairman - Justin Werner
|
15 Jul 2024 8:56AM |
$0.125 |
$0.140 |
risen by
12%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
